Recent research has identified human SLC35B1 as the key transporter for ATP entry into the ER, a groundbreaking discovery after three decades of investigation.
SLC35B1 differs from other transporters in substrate specificity, efficiently transporting ADP and ATP to support the ER's energy-demanding processes.
This finding is crucial for understanding intracellular nucleotide trafficking, especially in maintaining ER homeostasis during cellular stress.
Structurally, SLC35B1 features a unique substrate cavity that accommodates ATP molecules in a bent conformation, requiring a stepwise translocation strategy for transport.
The transporter's mechanism involves ATP binding to specific regions, such as hydrophobic patch interactions and ligand repositioning facilitated by gating helices.
SLC35B1's transport cycle includes vertical displacement of the ATP molecule and conformational shifts in gating helices for controlled translocation across the ER membrane.
The transporter exhibits complex intermediates in its transport cycle, suggesting a sophisticated mechanism similar to mitochondrial carriers for nucleotide movement.
The discovery of SLC35B1 raises questions about regulating nucleotide supply during cellular energy fluctuations and its potential implications for ER stress-related diseases.
Understanding SLC35B1 could offer insights into maintaining proteostasis, regulating energy distribution, and exploring therapeutic targets for ER stress-related disorders.
By integrating cryo-electron microscopy, biochemical kinetics, and genetic perturbation, this research provides a dynamic mechanistic model for transporter function at atomic resolution.